Mohsen Nafar

Mohsen Nafar

Auto-generated profile, based on publicly available information

Mohsen Nafar

Shahid Beheshti University of Medical Sciences

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SKShiva Kalantari
Shiva Kalantari
DRDorothea Rutishauser
Dorothea Rutishauser
SSShiva Samavat
Shiva Samavat
MNMohsen Nafar
Mohsen Nafar
LMLeyla Mahmudieh
Leyla Mahmudieh
JZJanet Zubarev
Janet Zubarev
IgA nephropathy is the most common cause of primary glomerulonephritis. There are different pathologic biopsy-based scoring systems in use, but there is no consensus among nephrologists yet regarding the best classification method. Our aim was to test urine proteomics as a non-invasive method for classification of IgA nephropathy. This aim was pursued by discovering novel prognostic protein biomarkers in urine, and linking them to pathogenesis of the disease through known signaling and metabolic pathways. 13 urine samples of the patients with biopsy-proven IgA nephropathy were analyzed via two proteomics approaches: nanoflow LC-MS/MS and GeLC-MS/MS. The results of label-free quantification were subjected to multivariate statistical analysis, which could classify patients into two groups, broadly corresponding to the primary and advance stages. The proteome classification correlated well with biopsy-based scoring systems, especially endocapillary hypercellularity score of the Oxford’s classification. Differentially excreted candidate proteins were found as potential prognostic biomarkers: afamin, leucine-rich alpha-2-glycoprotein, ceruloplasmin, alpha-1-microgolbulin, hemopexin, apolipoprotein A-I, complement C3, vitamin D-binding protein, beta-2-microglobulin, and retinol-binding protein 4. Pathway analysis suggested impairment of Extra Cellular Matrix (ECM)-Receptor Interaction pathways as well as activation of complement and coagulation pathway in progression of IgA nephropathy.

1 September 2005 in Transplantation Proceedings
Verified
Journal Article
Closed access
FPF. Pour-Reza-Gholi
F. Pour-Reza-Gholi
MNM. Nafar
M. Nafar
ASA. Saeedinia
A. Saeedinia
FFF. Farrokhi
F. Farrokhi
AFA. Firouzan
A. Firouzan
BEB. Einollahi
B. Einollahi

1 March 2006 in Transplantation Proceedings
Verified
Journal Article
Closed access
NSN. Simforoosh
N. Simforoosh
ABA. Basiri
A. Basiri
MFM.R. Fattahi
M.R. Fattahi
BEB. Einollahi
B. Einollahi
AFA. Firouzan
A. Firouzan
FFF. Farrokhi
F. Farrokhi

17 August 2007 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
MMMitra Mahdavi-Mazdeh
Mitra Mahdavi-Mazdeh
MZMahnaz Zamyadi
Mahnaz Zamyadi
MNMohsen Nafar
Mohsen Nafar
Background. Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are emerging as globally important public health problems, and will necessitate improvements in health-care policy. ESRD incidence/prevalence data are not available from large parts of the developing world. The main objective of this study is to describe and assess the current clinical practices for patients on maintenance haemodialysis (HD) living in the province of Tehran.

26 September 2003 in Nephrology
Verified
Journal Article
Closed access
PDF file
SASeyed Moayed Alavian
Seyed Moayed Alavian
BEBehzad Einollahi
Behzad Einollahi
BHBehzad Hajarizadeh
Behzad Hajarizadeh
SBSiamak Bakhtiari
Siamak Bakhtiari
MNMohsen Nafar
Mohsen Nafar
SASadegh Ahrabi
Sadegh Ahrabi

1 April 2013 in International Journal for Vitamin and Nutrition Research
Verified
Journal Article
Closed access
NNNazanin Noori
Nazanin Noori
HTHadi Tabibi
Hadi Tabibi
FHFarhad Hosseinpanah
Farhad Hosseinpanah
MHMehdi Hedayati
Mehdi Hedayati
MNMohsen Nafar
Mohsen Nafar
This study was designed to investigate the effects of combined administration of lipoic acid and pyridoxine on albuminuria, oxidative stress, blood pressure, serum advanced glycation end-products, nitric oxide (NO), and endothelin-1 in patients with diabetic nephropathy. Thirty-four patients were randomly assigned to either a supplement group or a placebo group. The patients in the supplement group received 800 mg lipoic acid and 80 mg pyridoxine daily for 12 weeks, whereas the placebo group received corresponding placebos. Urinary albumin, serum malondialdehyde (MDA), and systolic blood pressure decreased significantly in the supplement group compared to the placebo group (p < 0.05). Serum NO increased in the supplement group compared to the placebo group (p < 0.05). Serum pentosidine and carboxymethyl lysine decreased significantly in the supplement group at the end of week 12 compared to baseline (p < 0.05). No statistically significant differences were observed between the two groups in mean changes of serum endothelin-1, glucose, and diastolic blood pressure. The present study indicates that combined administration of lipoic acid and pyridoxine improves albuminuria in patients with diabetic nephropathy by reducing oxidative stress, advanced glycation end-products, and systolic blood pressure. The reduction in microalbuminuria may be of benefit in retarding the progression of diabetic nephropathy.